The M2–2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
The M2 mRNA of human respiratory syncytial virus (RSV) contains two overlapping ORFs, encoding the transcription antitermination protein (M2–1) and the 90-aa M2–2 protein of unknown function. Viable recombinant RSV was recovered in which expression of M2–2 was ablated, identifying it as an accessory factor dispensable for growth in vitro . Virus lacking M2–2 grew less efficiently than did the wild-type parent in vitro , with titers that were reduced 1,000-fold during the initial 2–5 days and 10-fold by days 7–8. Compared with wild-type virus, the intracellular accumulation of RNA by M2–2 knockout virus was reduced 3- to 4-fold or more for genomic RNA and increased 2- to 4-fold or more for mRNA. Synthesis of the F and G glycoproteins, the major RSV neutralization and protective antigens, was increased in proportion with that of mRNA. In cells infected with wild-type RSV, mRNA accumulation increased dramatically up to approximately 12–15 hr after infection and then leveled off, whereas accumulation continued to increase in cells infected with the M2–2 knockout viruses. These findings suggest that M2–2 mediates a regulatory “switch” from transcription to RNA replication, one that provides an initial high level of mRNA synthesis followed by a shift in the RNA synthetic program in favor of genomic RNA for virion assembly. With regard to vaccine development, the M2–2 knockout has a highly desirable phenotype in which virus growth is attenuated while gene expression is concomitantly increased.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fuerst, T. R., Niles, E. G., Studier, F. W., & Moss, B. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.21.8122 · Cited by 2,089
Collins, P. L., Hill, M. G., Camargo, E., Grosfeld, H., Chanock, R. M., & Murphy, B. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11563 · Cited by 450
Self-citationCollins, P. L., Hill, M. G., Cristina, J., & Grosfeld, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.81 · Cited by 296
Self-citationWhitehead, S. S., Bukreyev, A., Teng, M. N., Firestone, C.-Y., St. Claire, M., Elkins, W. R., Collins, P. L., & Murphy, B. R. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.3438-3442.1999 · Cited by 237
Self-citationGrosfeld, H., Hill, M. G., & Collins, P. L. (1995) · Journal of Virology · doi:10.1128/jvi.69.9.5677-5686.1995 · Cited by 226
Self-citationThe paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis
Kato, A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.3.578 · Cited by 209
Hardy, R. W., & Wertz, G. W. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.520-526.1998 · Cited by 178
Ribosomal initiation from an ACG codon in the Sendai virus P/C mRNA.
Curran, J., & Kolakofsky, D. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02806.x · Cited by 171
Horvath, C. M., Williams, M. A., & Lamb, R. A. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07446.x · Cited by 130
Sendai Virus Y Proteins Are Initiated by a Ribosomal Shunt
Latorre, P., Kolakofsky, D., & Curran, J. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.9.5021 · Cited by 125
Cited by
Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment
Griffiths, C., Drews, S. J., & Marchant, D. J. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00010-16 · Cited by 586
Viral and Host Factors in Human Respiratory Syncytial Virus Pathogenesis
Collins, P. L., & Graham, B. S. (2008) · Journal of Virology · doi:10.1128/jvi.01625-07 · Cited by 486
Self-citationAnalysis of the Genomic Sequence of a Human Metapneumovirus
van den Hoogen, B. G., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2002) · Virology · doi:10.1006/viro.2001.1355 · Cited by 479
Collins, P. L., & Melero, J. A. (2011) · Virus Research · doi:10.1016/j.virusres.2011.09.020 · Cited by 455
Self-citationRespiratory syncytial virus entry and how to block it
Battles, M. B., & McLellan, J. S. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0149-x · Cited by 402
Respiratory Syncytial Virus: Virology, Reverse Genetics, and Pathogenesis of Disease
Collins, P. L., Fearns, R., & Graham, B. S. (2013) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-38919-1_1 · Cited by 380
Self-citationEpidemiology of Human Metapneumovirus
Kahn, J. S. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00014-06 · Cited by 355
“During infection with a recombinant hMPV lacking M2-2 or with a recombinant RSV lacking M2-2, there is accumulation of viral mRNA compared with viral genome template (7, 17).”
BackgroundGenetic diversity between human metapneumovirus subgroups
Biacchesi, S., Skiadopoulos, M. H., Boivin, G., Hanson, C. T., Murphy, B. R., Collins, P. L., & Buchholz, U. J. (2003) · Virology · doi:10.1016/s0042-6822(03)00528-2 · Cited by 269
Self-citationBovine respiratory syncytial virus infection
Valarcher, J.-F., & Taylor, G. (2007) · Veterinary Research · doi:10.1051/vetres:2006053 · Cited by 267
Human Metapneumovirus: Lessons Learned over the First Decade
Schildgen, V., van den Hoogen, B., Fouchier, R., Tripp, R. A., Alvarez, R., Manoha, C., Williams, J., & Schildgen, O. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00015-11 · Cited by 244
“For RSV, the M2-2 protein is thought to play a role in shifting the balance of RNA synthesis from mRNA to vRNA (20).”
BackgroundRespiratory Syncytial Virus Vaccines
Dudas, R. A., & Karron, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.3.430 · Cited by 191
Radhakrishnan, A., Yeo, D., Brown, G., Myaing, M. Z., Iyer, L. R., Fleck, R., Tan, B.-H., Aitken, J., Sanmun, D., Tang, K., et al. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.001651 · Cited by 114
Quantitative Proteomic Analysis of A549 Cells Infected with Human Respiratory Syncytial Virus
Munday, D. C., Emmott, E., Surtees, R., Lardeau, C.-H., Wu, W., Duprex, W. P., Dove, B. K., Barr, J. N., & Hiscox, J. A. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.001859 · Cited by 92
“The L protein is the catalytic component of the replicase-transcriptase complex and possesses RNA-dependent RNA polymerase activity.”
BackgroundVaccines against human respiratory syncytial virus in clinical trials, where are we now?
Rossey, I., & Saelens, X. (2019) · Expert Review of Vaccines · doi:10.1080/14760584.2019.1675520 · Cited by 32
“A deletion in the M2-2 gene results in a shift of the balance from genome replication to viral gene transcription, leading to an increase in synthesis of potentially immunogenic viral proteins, yet a decrease in replicating virus [67].”
Background
Metadata
- Authors
- Bermingham, A., & Collins, P. L.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1999-09-28
- Volume
- 96
- Issue
- 20
- Pages
- 11259-11264
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1974546818
- Cited by
- 278
- References
- 13
- FWCI
- 7.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.